Precision BioSciences, Inc. Financial Ratios — DTIL Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-43.58	-49.69	-56.57	-16.92	-49.65	-30.82	4.84	-31.45
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-1.97	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	-38.31	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-314.94	-418.62	-368.23	-411.84	-25.26	-212.38	-72.82	-31.42	-144.16
Operating Margin (%)	-337.08	-440.25	-392.14	-452.25	-34.08	-248.26	-89.76	-38.08	-152.19
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-325.45	-423.02	-417.65	-448.86	-26.49	-290.5	-87.28	10.43	-136.03
Profit Margin (%)	-325.45	-423.02	-417.65	-448.86	-26.49	-444.8	-125.84	10.43	-133.45
Net Income to Common Margin (%)	-325.45	-423.02	-417.65	-448.86	-26.49	-444.8	-125.84	10.43	-133.45
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	11	9	25	31	30	29
ST Debt	- -	- -	- -	2	2	2	24	1	2
LT Debt	- -	- -	- -	9	7	23	8	29	27
Total Debt/EBITDA	- -	- -	- -	-0.11	-0.31	-0.47	-0.88	-1.39	-0.58
Net Debt/EBITDA	3.08	2.27	2.21	0.9	4.84	3.14	2.66	2.95	1.79
Total Debt/EBIT	- -	- -	- -	-0.1	-0.23	-0.4	-0.71	-1.15	-0.55
Net Debt/EBIT	2.87	2.15	2.07	0.82	3.59	2.69	2.16	2.43	1.7
EBITDA to Interest Expense	- -	- -	-449.93	- -	-221.05	-47.98	-15.91	-12.11	-34.74
EBITDA-CapEx/Interest Expense	- -	- -	-585.46	- -	-265.02	-50.97	-16.93	-12.27	-35.23
EBIT to Interest Expense	- -	- -	-479.14	- -	-298.3	-56.08	-19.61	-14.68	-36.67
Interest Expense	- -	- -	- -	- -	- -	1	2	2	1
Common Equity/Total Assets	-53.81	-61.46	-75.27	-190.51	-149.73	-179.83	-306.44	-353.74	-342.05
Long-Term Debt/Equity (%)	- -	- -	- -	19.33	8	38.53	40.95	50.94	29.6
Long-Term Debt/Capital (%)	- -	- -	- -	-3.12	-2.37	-5.77	-1.68	-6.35	-5.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	5.72	3.45	9.78	4.83	21.06	17.68
Total Debt/Equity (%)	- -	- -	- -	23.68	10	41.3	165.78	53.28	31.23
Total Debt/Capital (%)	- -	- -	- -	-3.82	-2.96	-6.19	-6.82	-6.64	-5.77
Total Debt/Total Assets (%)	- -	- -	- -	7.01	4.31	10.48	19.57	22.03	18.66
Net Debt to Equity	238.17	-258.24	-130.78	-202.13	-154.86	-276.92	-499.79	-112.74	-95.85
Net Debt/Capital (%)	61.62	54.78	50.53	24.58	31.29	28.22	16.39	11.81	14.49
EBITDA	-20	-46	-82	-100	-29	-53	-35	-22	-49
EBITDA-CapEx	-26	-61	-107	-105	-35	-57	-38	-22	-50
Operating Income (Loss)	-22	-48	-87	-110	-39	-62	-44	-26	-52

Liquidity (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	6.82	7.33	6.72	2.1	3.99	3.18	2.33	5.76	12.97
Current Ratio	6.99	8.22	7.19	2.46	4.5	3.34	2.73	6.34	13.32
Quick Ratio	6.83	7.37	6.75	2.33	4.01	3.19	2.59	5.88	12.97
CFO/Avg Current Liab	- -	-4.44	-3.46	-2.51	-0.28	-0.96	-1.53	-1.8	-5.51
Common Equity/Total Assets	-53.81	-61.46	-75.27	-190.51	-149.73	-179.83	-306.44	-353.74	-342.05
Long-Term Debt/Equity (%)	- -	- -	- -	19.33	8	38.53	40.95	50.94	29.6
Long-Term Debt/Capital (%)	- -	- -	- -	-3.12	-2.37	-5.77	-1.68	-6.35	-5.47
Long-Term Debt/Total Assets (%)	- -	- -	- -	5.72	3.45	9.78	4.83	21.06	17.68
Total Debt/Equity (%)	- -	- -	- -	23.68	10	41.3	165.78	53.28	31.23
Total Debt/Capital (%)	- -	- -	- -	-3.82	-2.96	-6.19	-6.82	-6.64	-5.77
Total Debt/Total Assets (%)	- -	- -	- -	7.01	4.31	10.48	19.57	22.03	18.66
CFO/Total Liabilities	-24.4	-52.44	-73.27	-82.65	-9.02	-25.74	-59.69	-73.06	-105.91
CFO/CapEx	-4.34	-3.3	-2.88	-17.37	-1.87	-13.79	-36.92	-212.53	-94.06
Altman's Z-Score	-0.75	-1.05	2.27	-2	0.7	-2.23	-4.07	-4.2	-4.35

Working Capital (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	41.62	29.89	4.43	22.03	41.55	60.12	121.59	299.25
Days Sales Outstanding	- -	8.77	12.21	82.4	16.57	8.78	6.07	3	1.22
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	583	434	434	105	42	26	53
- Cash & Cash Equivalents	63	103	181	90	144	190	117	86	111
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	11	9	25	31	30	29
Enterprise Value	-63	-103	402	355	300	-60	-43	-30	-33
Total Capital	-39	-85	-177	-276	-308	-403	-458	-452	-499
Total Debt/Capital (%)	- -	- -	- -	-3.82	-2.96	-6.19	-6.82	-6.64	-5.77
Total Debt / EV	- -	- -	- -	0.03	0.03	-0.42	-0.72	-0.99	-0.86
EV/Sales	- -	- -	18.09	14.6	2.59	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	583	434	434	105	42	26	53
Diluted Enterprise Value	-63	-103	402	355	300	-60	-43	-30	-29
EV per Share	- -	- -	287.47	204.49	153.22	- -	- -	- -	- -
TTM Sales	6	11	22	24	116	25	49	69	34
TTM EBITDA	-20	-46	-82	-100	-29	-53	-35	-22	-49
TTM Operating Income	-22	-48	-87	-110	-39	-62	-44	-26	-52
TTM Cash Flow to Firm	-24	-52	-71	-87	-11	-45	-82	-57	-64
TTM Free Cash Flow to Firm	-19	-36	-46	-82	-5	-41	-80	-56	-64

Multiples (USD)

API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	-12.58	-5.27	-86	-2.46	-0.51	-0.45	-0.82
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-63	-103	402	355	300	-60	-43	-30	-33
Low Price	- -	- -	187.2	133.65	219	28.5	8.25	3.61	4.02
EV/Sales	- -	- -	18.09	14.6	2.59	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	3.63	- -
Price/Earnings Average	- -	- -	-5.26	-3.68	-20.25	-1.84	-1.28	9.73	-1.44
Price/Earnings High	- -	- -	-10.7	-7.19	-31.84	-6.18	-2.73	18.52	-2.47
Price/Earnings Low	- -	- -	-2.82	-2.13	-14	-0.75	-0.52	3.44	-1.13
Price/Book Value	- -	- -	-3.29	-1.52	-1.37	-0.24	-0.09	-0.05	-0.1
Price/Book Value Average	- -	- -	-2.76	-1.4	-1.96	-0.48	-0.16	-0.14	-0.12
Price/Book Value High	- -	- -	-5.61	-2.74	-3.08	-1.61	-0.34	-0.28	-0.21
Price/Book Value Low	- -	- -	-1.48	-0.81	-1.35	-0.19	-0.06	-0.05	-0.1
Price/Tangible Book Value	- -	- -	4.26	10.08	4.87	1.75	2.28	0.47	0.59
Price/Tangible Book Value Average	- -	- -	3.57	9.31	6.95	3.44	4.25	1.25	0.72
Price/Tangible Book Value High	- -	- -	7.26	18.21	10.93	11.56	9.05	2.38	1.24
Price/Tangible Book Value Low	- -	- -	1.91	5.38	4.81	1.4	1.72	0.44	0.57
Price/Sales	- -	- -	26.23	17.87	3.76	4.17	0.86	0.38	1.56
Price/Sales Average	- -	- -	21.97	16.5	5.36	8.18	1.61	1.02	1.92
Price/Sales High	- -	- -	44.7	32.29	8.43	27.49	3.43	1.93	3.3
Price/Sales Low	- -	- -	11.78	9.55	3.71	3.33	0.65	0.36	1.5
Price/Cash Flow	- -	- -	-8.21	-4.97	-40.02	-2.29	-0.5	-0.45	-0.81
Price/Cash Flow Average	- -	- -	-6.88	-4.58	-57.11	-4.49	-0.93	-1.19	-1
Price/Cash Flow High	- -	- -	-14	-8.97	-89.77	-15.08	-1.99	-2.27	-1.72
Price/Cash Flow Low	- -	- -	-3.69	-2.65	-39.48	-1.83	-0.38	-0.42	-0.78
Price/Free Cash Flow Average	- -	- -	-10.54	-4.86	-122.73	-4.84	-0.96	-1.21	-1.01
Price/Free Cash Flow High	- -	- -	-21.44	-9.52	-192.92	-16.26	-2.04	-2.3	-1.74
Price/Free Cash Flow Low	- -	- -	-5.65	-2.81	-84.84	-1.97	-0.39	-0.43	-0.79
EV/Sales Average	- -	- -	13.84	13.23	4.2	1.62	- -	0.2	- -
EV/Sales High	- -	- -	36.56	29.02	7.27	20.93	1.68	1.12	0.91
EV/Sales Low	- -	- -	3.65	6.28	2.54	- -	- -	- -	- -
EV/EBITDA Average	3.08	2.26	-3.76	-3.21	-16.63	-0.76	0.2	-0.64	0.33
EV/EBITDA High	3.08	2.26	-9.93	-7.05	-28.78	-9.86	-2.3	-3.56	-0.63
EV/EBITDA Low	3.08	2.26	-0.99	-1.52	-10.07	1.52	1.51	1.44	0.62
EV/EBIT Average	2.87	2.15	-3.53	-2.93	-12.32	-0.65	0.16	-0.53	0.31
EV/EBIT High	2.87	2.15	-9.32	-6.42	-21.32	-8.43	-1.87	-2.94	-0.6
EV/EBIT Low	2.87	2.15	-0.93	-1.39	-7.46	1.3	1.23	1.19	0.58
Last Price	- -	- -	416.7	250.2	222	35.7	10.95	3.81	4.16
High Price	- -	- -	710.1	452.1	498	235.5	43.5	19.43	8.82
Enterprise Value Average	-63	-103	308	321	485	41	-7	14	-16
Enterprise Value High	-63	-103	813	705	840	525	82	77	31
Enterprise Value Low	-63	-103	81	153	294	-81	-54	-31	-30

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	2	2	2	2	2	4	4	8	24
Diluted Weighted Avg Shares	1	2	1	2	2	3	4	7	13
Basic Weighted Avg Shares	1	2	1	2	2	3	4	7	13
Revenue per Share	5.78	6.66	15.89	14	59.06	8.57	12.68	10.05	2.67
EBITDA per Share	-18.2	-27.88	-58.5	-57.67	-14.92	-18.19	-9.24	-3.16	-3.85
Operating Income per Share	-19.48	-29.32	-62.3	-63.32	-20.13	-21.27	-11.39	-3.83	-4.07
Basic EPS, GAAP	-18.81	-28.17	-66.35	-62.85	-15.64	-38.1	-15.96	1.05	-3.56
Basic EPS from Cont Ops	-18.81	-28.17	-66.35	-62.85	-15.64	-24.88	-11.07	1.05	-3.63
Diluted EPS, GAAP	-18.81	-28.17	-66.35	-62.85	-15.64	-38.1	-15.96	1.04	-3.56
Diluted EPS from Cont Ops	-18.81	-28.17	-66.35	-62.85	-15.64	-24.88	-11.07	1.04	-3.63
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-21.54	-31.65	-50.74	-50.38	-5.55	-15.62	-21.9	-8.55	-5.13
Free Cash Flow per Basic Share	-26.51	-41.24	-68.36	-53.28	-8.51	-16.75	-22.49	-8.59	-5.19
Cash & Equivalents per Share	55.98	63.14	129.23	51.77	73.44	64.7	30.37	12.63	9.01
Book Value per Share	-34.86	-52.12	-126.5	-164.94	-161.88	-146.18	-127.46	-70.61	-41.18
Tangible Book Value per Share	-23.59	23.55	97.79	24.82	45.56	20.38	4.81	8.16	7.1

Precision BioSciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)